3 Things About Moderna That Smart Investors Know
As the biotech responsible for developing one of the world's first safe and effective messenger RNA (mRNA) vaccines against the coronavirus, Moderna (NASDAQ: MRNA) is by definition a technologically sophisticated operator. What's more, its pipeline is chock-full of exciting new projects that could treat some of the world's most difficult conditions.
But as smart investors know, the social utility of a business doesn't always correspond to the chances of an investment paying off. Nor does being an early leader in a breakthrough space guarantee a perpetual seat on the throne. So let's explore three high-impact things that experienced investors are likely to understand about Moderna and which are likely to shape their decisions about the stock.
Image source: Getty Images.
Source Fool.com
